In a study in which palmatine (PAL) improved experimental colitis in rats, PAL significantly increased the expression levels of METTL3, METTL14, and ZO-1 and repaired intestinal barrier dysfunction (Ji et al., 2024). Here, TJP1 is linked to colitis.